Cargando…

Clinical and economic outcomes among hospitalized patients with acute coronary syndrome: an analysis of a national representative Medicare population

OBJECTIVE: To evaluate the clinical and economic burden of acute coronary syndrome (ACS), a common cardiovascular illness, in the Medicare population. METHODS: Data from the Medicare Current Beneficiary Survey were analyzed. Patients with incident hospitalization for ACS without similar events durin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Shih-Yin, Crivera, Concetta, Stokes, Michael, Boulanger, Luke, Schein, Jeffrey
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2013
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3645904/ https://www.ncbi.nlm.nih.gov/pubmed/23662068 http://dx.doi.org/10.2147/CEOR.S43672

Ejemplares similares

Outcomes associated with comorbid atrial fibrillation and heart failure in medicare beneficiaries with acute coronary syndrome
por: Chen, Shih-Yin, et al.
Publicado: (2014)

Validation of the multivariable In-hospital Mortality for PulmonAry embolism using Claims daTa (IMPACT) prediction rule within an all-payer inpatient administrative claims database
por: Coleman, Craig I, et al.
Publicado: (2015)

Shorter Hospital Stays and Lower Costs for Rivaroxaban Compared With Warfarin for Venous Thrombosis Admissions
por: Margolis, Jay M., et al.
Publicado: (2016)

Clinical and Economic Outcomes in Low-risk Pulmonary Embolism Patients Treated with Rivaroxaban versus Standard of Care
por: Peacock, W. Frank, et al.
Publicado: (2019)

Attitudes toward anticoagulant treatment among nonvalvular atrial fibrillation patients at high risk of stroke and low risk of bleed
por: Crivera, Concetta, et al.
Publicado: (2016)

Economic Burden of Osteoporosis-Related Fractures in the US Medicare Population
por: Williams, Setareh A., et al.
Publicado: (2020)

Predictors of Hospital Length of Stay among Patients with Low-risk Pulmonary Embolism
por: Wang, Li, et al.
Publicado: (2019)

Economic burden of hospitalizations of Medicare beneficiaries with heart failure
por: Kilgore, Meredith, et al.
Publicado: (2017)

Clinical outcomes of prolonged anticoagulation with rivaroxaban after unprovoked venous thromboembolism
por: Berger, Jeffrey S., et al.
Publicado: (2017)

Abstract 90: Economic Benefit of Carpal Tunnel Syndrome Treatment in the Medicare Patient Population
por: Hubbard, Zachary, et al.
Publicado: (2017)

Erratum to: Effect of Rivaroxaban Versus Warfarin on Health Care Costs Among Nonvalvular Atrial Fibrillation Patients: Observations from Rivaroxaban Users and Matched Warfarin Users
por: Laliberté, François, et al.
Publicado: (2015)

Effect of Rivaroxaban Versus Warfarin on Health Care Costs Among Nonvalvular Atrial Fibrillation Patients: Observations from Rivaroxaban Users and Matched Warfarin Users
por: Laliberté, François, et al.
Publicado: (2015)

Potential epidemiologic, economic, and budgetary impacts of current rates of hepatitis C treatment in medicare and non‐medicare populations
por: Wittenborn, John, et al.
Publicado: (2017)

External validation of a multivariable claims-based rule for predicting in-hospital mortality and 30-day post-pulmonary embolism complications
por: Coleman, Craig I., et al.
Publicado: (2016)

The risk of recurrent VTE and major bleeding in a commercially‐insured population of cancer patients treated with anticoagulation
por: Khorana, Alok A., et al.
Publicado: (2018)

Benefit of early discharge among patients with low-risk pulmonary embolism
por: Wang, Li, et al.
Publicado: (2017)

Medicare and Hospitals
por: Rabkin, Mitchell T.
Publicado: (1996)

Validation of Self‐Reported Rheumatoid Arthritis Using Medicare Claims: A Nationally Representative Longitudinal Study of Older Adults
por: Booth, Michael J., et al.
Publicado: (2021)

The Medicare Economic Index: Its Background and Beginnings
por: Dutton, Benson L., et al.
Publicado: (1981)

One-Year Adherence to Warfarin Treatment for Venous Thromboembolism in High-Risk Patients and Its Association with Long-term Risk of Recurrent Events
por: Chen, Shih-Yin, et al.
Publicado: (2013)

Medicare & You: Assessment of the National Medicare Education Program: Supply and Demand for Information
Publicado: (1999)

Economic burden of acute coronary syndrome in South Korea: a national survey
por: Kim, Jinhyun, et al.
Publicado: (2013)

Early Adoption of Dupilumab in the Medicare Population in 2017
por: Cheraghlou, Shayan, et al.
Publicado: (2020)

Growth of the Medicare population
por: Mariano, L. Antonio
Publicado: (1989)

Duration of anticoagulant therapy and VTE recurrence in patients with cancer
por: Khorana, Alok A., et al.
Publicado: (2019)

Social and Economic Determinants of Medicare Managed Care Participation
por: Heller, Amy
Publicado: (2005)

Setting Physicians' Prices in FFS Medicare: An Economic Perspective
por: Dowd, Bryan, et al.
Publicado: (2006)

The Economics of Skin Cancer: An Analysis of Medicare Payment Data
por: Chen, Jenny T., et al.
Publicado: (2016)

The economic burden of Parkinson disease among Medicare beneficiaries
por: Albarmawi, Husam, et al.
Publicado: (2022)

Medicare & You: Information Needs and Preferences of the General Medicare Population
Publicado: (1999)

Impact of the Medicare hospital readmissions reduction program on vulnerable populations
por: Gai, Yunwei, et al.
Publicado: (2019)

Economic Impact of an Advanced Illness Consultation Program within a Medicare Advantage Plan Population
por: Colaberdino, Vincent, et al.
Publicado: (2016)

Medicare & You: Information Needs and Preferences of the Medicare Population with Vision Loss
Publicado: (2000)

Current practice patterns and patient persistence with anticoagulant treatments for cancer‐associated thrombosis
por: Khorana, Alok A., et al.
Publicado: (2017)

Changes in Medicare Reimbursement in Colorado: Impact on Physicians' Economic Behavior
por: Rice, Thomas, et al.
Publicado: (1982)

Measuring input prices for physicians: The revised Medicare Economic Index
por: Freeland, Mark S., et al.
Publicado: (1991)

Contemporary economic burden in a real‐world heart failure population with Commercial and Medicare supplemental plans
por: Lam, Carolyn S. P., et al.
Publicado: (2021)

Rates of Hospitalization for Ambulatory Care Sensitive Conditions in the Medicare+Choice Population
por: McCall, Nancy, et al.
Publicado: (2001)

External validation of prognostic rules for early post-pulmonary embolism mortality: assessment of a claims-based and three clinical-based approaches
por: Weeda, Erin R., et al.
Publicado: (2016)

Increased hospitalizations and economic burden in COPD with bronchiectasis: a nationwide representative study
por: Kim, Youlim, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_t471qsqeps7h1bpm0e023t659b